Savient Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2013 to a ratio of 3.2, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2013. Average collection period, for Savient Pharmaceuticals Inc's accounts receivable remained unchanged at 114 days, in the Sep 30 2013 quarter.

If we take a look into Healthcare sector 82 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1051, from overall ranking in the second quarter 2013 at 1094.

What is Receivable Turnover Ratio?
What is Savient Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SVNT Receivables Turnover Ratio	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter
Y / Y Receivable Change	41.5 %	36.57 %	-26.05 %	-8.36 %	29.93 %
Y / Y Revenue Change	33.58 %	44.01 %	-	33.34 %	90.47 %
Receivable Turnover Ratio (TTM)	3.2	3.19	3.11	3.6	3.29
SVNT's Total Ranking	# 1051	# 1094	# 946	# 0	#
Accounts Receivable average collection period days	114	115	118	101	111
Seq. Receivable Change	-12.05 %	102.75 %	-11.91 %	-9.92 %	-15.11 %
Seq. Revenue Change	-1.43 %	-	-	0.63 %	6.27 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 13
Healthcare Sector	# 83
Overall Market	# 1051

Receivable Turnover Ratio Statistics
High	Average	Low
0.16	0.14	0.12
(Jun 30 2013)		(Dec 31 2012)

SVNT Company Profile • Back to SVNT Efficiency Comparisons • Compare SVNT Receivables Turnover Ratio to its Competitors

Financial Statements
Savient Pharmaceuticals Inc's Accounts Receivable	$ 7 Millions	Visit SVNT's Balance sheet
Savient Pharmaceuticals Inc's Sales TTM	$ 18 Millions	Visit SVNT's Income Statement
Sources of SVNT's Revenues		Visit SVNT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SVNT's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SVNT's Growth Rates	SVNT's Roa	SVNT's Inventory Turnover Ratio	SVNT's Dividend Comparisons
SVNT's Profitability Ratios	SVNT's Roi	SVNT's Asset Turnover Ratio	SVNT's Dividend Growth
SVNT's Valuation Ratios	SVNT's Roe	SVNT's Financial Strength Ratios	SVNT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2013	Receivable at quarter ending Sep 30 2013
Antares Pharma Inc	7.31	$ 21.375 Millions	$ 2.923 Millions
Integra Lifesciences Holdings Corp	7.29	$ 829.877 Millions	$ 113.787 Millions
Tivity Health Inc	7.25	$ 669.229 Millions	$ 92.269 Millions
Select Medical Holdings Corp	7.25	$ 2,970.559 Millions	$ 409.756 Millions
Atricure Inc	7.21	$ 78.369 Millions	$ 10.865 Millions
Medicines Co	7.15	$ 662.351 Millions	$ 92.605 Millions
Stablecoin Development Corporation	7.14	$ 4.002 Millions	$ 0.561 Millions
Insulet Corporation	7.13	$ 236.379 Millions	$ 33.130 Millions
Enzo Biochem Inc	7.12	$ 92.211 Millions	$ 12.943 Millions
Luminex Corporation	7.12	$ 213.802 Millions	$ 30.044 Millions
West Pharmaceutical Services Inc	7.11	$ 1,347.200 Millions	$ 189.375 Millions
Nuvasive Inc	7.10	$ 660.112 Millions	$ 92.973 Millions
Insite Vision Inc	7.07	$ 35.167 Millions	$ 4.978 Millions
Allergan plc	7.05	$ 6,124.900 Millions	$ 869.375 Millions
Tenet Healthcare Corp	7.04	$ 9,548.000 Millions	$ 1,355.500 Millions
Healthcare Services Group Inc	7.02	$ 1,123.096 Millions	$ 159.925 Millions
Aethlon Medical Inc	7.01	$ 1.454 Millions	$ 0.207 Millions
Veru Inc	7.01	$ 31.457 Millions	$ 4.487 Millions
Nrc Health	7.00	$ 91.663 Millions	$ 13.099 Millions
Prophase Labs Inc	6.97	$ 24.509 Millions	$ 3.516 Millions
3m Company	6.97	$ 30,689.000 Millions	$ 4,403.750 Millions
Amgen Inc	6.96	$ 18,086.000 Millions	$ 2,597.500 Millions
Rayont Inc	6.92	$ 0.966 Millions	$ 0.140 Millions
Invacare Holdings Corporation	6.92	$ 1,374.883 Millions	$ 198.751 Millions
Seagen Inc	6.86	$ 265.767 Millions	$ 38.760 Millions
Neurocrine Biosciences Inc	6.79	$ 24.136 Millions	$ 3.553 Millions
The Cooper Companies Inc	6.79	$ 1,587.725 Millions	$ 233.905 Millions
Intuitive Surgical Inc	6.79	$ 2,298.200 Millions	$ 338.650 Millions
Eli Lilly And Company	6.74	$ 23,261.600 Millions	$ 3,450.025 Millions
Alpha Pro Tech Ltd	6.73	$ 43.146 Millions	$ 6.408 Millions

Date modified: 2026-09-02T17:38:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.